Companies › GENB

GENERATE BIOMEDICINES INC (GENB)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0002100782 · EDGAR filings · Updated 2026-05-15

GENERATE BIOMEDICINES INC (GENB) has reported institutional ownership of 72.4%, with 57 institutional managers holding positions valued at $1.16B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-05-15 — SCHEDULE 13G filed
• 2026-05-15 — SCHEDULE 13G filed
• 2026-05-07 — Quarterly report (10-Q) filed
• 2026-05-07 — Current report (8-K) filed
• 2026-03-12 — Initial insider ownership filed (Form 3)
• 2026-03-06 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, GENERATE BIOMEDICINES INC has 57 institutional holders and institutional ownership of 72.4%.

Insider activity

Insiders reported 24 transactions (12 buys, 0 sells) across 11 reporting insiders, with a net reported value of $150.3M.

Data flags from SEC filings

Related companies

ORGANON & CO (OGN) · MOONLAKE IMMUNOTHERAPEUTICS (MLTX) · SAVARA INC (SVRA) · EYEPOINT INC COM NEW (EYPT) · PHIBRO ANIMAL HEALTH CORP (PAHC) · SEPTERNA INC (SEPN)